Fresenius SE & Co. (OTCMKTS:FSNUY) Releases Earnings Results, Misses Expectations By $0.01 EPS

Fresenius SE & Co. (OTCMKTS:FSNUY) posted its earnings results on Wednesday. The company reported $0.24 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01), Zacks reports. Fresenius SE & Co. had a return on equity of 10.31% and a net margin of 5.71%.

Fresenius SE & Co. Price Performance

FSNUY stock traded up $0.30 during mid-day trading on Wednesday, hitting $11.91. The stock had a trading volume of 70,514 shares, compared to its average volume of 142,768. The company has a current ratio of 1.32, a quick ratio of 1.00 and a debt-to-equity ratio of 0.47. Fresenius SE & Co. has a 52 week low of $11.28 and a 52 week high of $33.93. The firm has a market capitalization of $26.83 billion, a P/E ratio of 18.91 and a beta of 0.68. The firm has a fifty day simple moving average of $13.13 and a 200 day simple moving average of $14.16.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on FSNUY. Citigroup reaffirmed a “buy” rating on shares of Fresenius SE & Co. in a research report on Tuesday, February 3rd. Morgan Stanley reaffirmed an “overweight” rating on shares of Fresenius SE & Co. in a research report on Monday, April 20th. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat, the stock presently has an average rating of “Buy”.

Fresenius SE & Co. Company Profile

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.